Term ends Jul 11, 2031 · Medium confidence
20-year base term ends Jul 11, 2031
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 9,233,145), so the cap could be lower.
Jul 11, 2011
Jul 11, 2031
Apr 18, 2017
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 11, 2011, when application PCT/US2011/043569, the earliest non-provisional in its chain, was filed (this one was filed Feb 12, 2016) | Jul 11, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,233,145, US 9,629,903, US 9,670,475, US 9,675,676, US 9,867,873) | resolves to Jul 11, 2031, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 11, 2031 | Medium confidence |
This family
| Application PCT/US2011/043569 | PCT application no patent term | no patent term |
| US 9,233,145 | In force no later than Sep 2031 | no later than Sep 2031 |
| US 9,670,475 | In force Jul 2031 | Jul 2031 |
| US 9,867,873 | In force Jul 2031 | Jul 2031 |
| US 9,675,676 | In force Jul 2031 | Jul 2031 |
| US 9,623,091 | this patent Jul 2031 | Jul 2031 |
| US 9,629,903 | In force Jul 2031 | Jul 2031 |
| Application 15/820,080 | Abandoned not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 24, 2016 Reel 37899, frame 516 | Biogen Idec Hemophilia Inc. | Biogen Hemophilia Inc. | Change of Name |
| Feb 26, 2016 Reel 37841, frame 516 | Pierce, Glenn; Truex, Samantha; Peters, Robert T.; Jiang, Haiyan | Biogen Idec Hemophilia Inc. | Assignment of Assignor's Interest |
| Feb 16, 2017 Reel 41735, frame 703 | Biogen Hemophilia Inc. | Bioverativ Therapeutics Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 9,233,145, US 9,629,903, US 9,670,475, US 9,675,676, US 9,867,873, ends no earlier than this term, so it caps nothing.